Yep I think that wont be far away either.
- Upon completion of the potential acquisition, ECQ will be re-purposed as a biotechnology company with Cynata’s technology as its chief asset
Ann: CEO Presentation , page-3
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
